{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:09:02Z","timestamp":1751429342279,"version":"3.41.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04231-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:40:22Z","timestamp":1751359222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel gene signature for forecasting time to next relapse in multiple sclerosis using peripheral blood mononuclear cells"],"prefix":"10.1186","volume":"25","author":[{"given":"Huimin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"11","key":"4231_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","volume":"17","author":"N Koch-Henriksen","year":"2021","unstructured":"Koch-Henriksen N, Magyari M. Apparent changes in the epidemiology and severity of multiple sclerosis. Nat Rev Neurol. 2021;17(11):676\u201388.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"4231_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019;26(1):27\u201340.","journal-title":"Eur J Neurol"},{"key":"4231_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-med-042910-135833","volume":"63","author":"D Ontaneda","year":"2012","unstructured":"Ontaneda D, Hyland M, Cohen JA. Multiple sclerosis: new insights in pathogenesis and novel therapeutics. Annu Rev Med. 2012;63:389\u2013404.","journal-title":"Annu Rev Med"},{"issue":"4","key":"4231_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/biomedicines10040815","volume":"10","author":"G Scalabrino","year":"2022","unstructured":"Scalabrino G. Newly identified deficiencies in the multiple sclerosis central nervous system and their impact on the remyelination failure. Biomedicines. 2022;10(4):815.","journal-title":"Biomedicines"},{"key":"4231_CR5","doi-asserted-by":"publisher","first-page":"811518","DOI":"10.3389\/fneur.2021.811518","volume":"12","author":"O Perdaens","year":"2021","unstructured":"Perdaens O, van Pesch V. Molecular mechanisms of immunosenescene and inflammaging: relevance to the Immunopathogenesis and treatment of multiple sclerosis. Front Neurol. 2021;12:811518.","journal-title":"Front Neurol"},{"issue":"2","key":"4231_CR6","doi-asserted-by":"publisher","first-page":"e90482","DOI":"10.1371\/journal.pone.0090482","volume":"9","author":"H Irizar","year":"2014","unstructured":"Irizar H, Mu\u00f1oz-Culla M, Sep\u00falveda L, S\u00e1enz-Cuesta M, Prada \u00c1, Castillo-Trivi\u00f1o T, et al. Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression. PLoS ONE. 2014;9(2):e90482.","journal-title":"PLoS ONE"},{"issue":"9","key":"4231_CR7","first-page":"1086","volume":"13","author":"V Tomassini","year":"2007","unstructured":"Tomassini V, De Giglio L, Reindl M, Russo P, Pestalozza I, Pantano P, et al. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS, multiple sclerosis (Houndmills. Basingstoke England). 2007;13(9):1086\u201394.","journal-title":"Basingstoke England)"},{"issue":"4","key":"4231_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF03256329","volume":"13","author":"VK Harris","year":"2009","unstructured":"Harris VK, Sadiq SA. Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making. Mol Diagn Ther. 2009;13(4):225\u201344.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"4231_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","volume":"54","author":"V Martinsen","year":"2022","unstructured":"Martinsen V, Kursula P. Multiple sclerosis and Myelin basic protein: insights into protein disorder and disease. Amino Acids. 2022;54(1):99\u2013109.","journal-title":"Amino Acids"},{"issue":"2","key":"4231_CR10","first-page":"270","volume":"12","author":"AI AlTokhis","year":"2022","unstructured":"AlTokhis AI, AlAmrani A, Alotaibi A, Podlasek A, Constantinescu CS. Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome and multiple sclerosis: A systematic review and Meta-Analysis. Diagnostics (Basel Switzerland). 2022;12(2):270.","journal-title":"Diagnostics (Basel Switzerland)"},{"key":"4231_CR11","doi-asserted-by":"publisher","first-page":"679881","DOI":"10.3389\/fneur.2021.679881","volume":"12","author":"R Cortese","year":"2021","unstructured":"Cortese R, Giorgio A, Severa G, De Stefano N. MRI prognostic factors in multiple sclerosis, neuromyelitis Optica spectrum disorder, and Myelin oligodendrocyte antibody disease. Front Neurol. 2021;12:679881.","journal-title":"Front Neurol"},{"key":"4231_CR12","doi-asserted-by":"publisher","first-page":"700582","DOI":"10.3389\/fimmu.2021.700582","volume":"12","author":"F Moazami","year":"2021","unstructured":"Moazami F, Lefevre-Utile A, Papaloukas C, Soumelis V. Machine learning approaches in study of multiple sclerosis disease through magnetic resonance images. Front Immunol. 2021;12:700582.","journal-title":"Front Immunol"},{"key":"4231_CR13","doi-asserted-by":"publisher","first-page":"579683","DOI":"10.3389\/fneur.2020.579683","volume":"11","author":"F Ye","year":"2020","unstructured":"Ye F, Liang J, Li J, Li H, Sheng W. Development and validation of a Five-Gene signature to predict Relapse-Free survival in multiple sclerosis. Front Neurol. 2020;11:579683.","journal-title":"Front Neurol"},{"key":"4231_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1755-8794-2-46","volume":"2","author":"M Gurevich","year":"2009","unstructured":"Gurevich M, Tuller T, Rubinstein U, Or-Bach R, Achiron A. Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells. BMC Med Genomics. 2009;2:46.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"4231_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40659-021-00334-6","volume":"54","author":"X Chen","year":"2021","unstructured":"Chen X, Hou H, Qiao H, Fan H, Zhao T, Dong M. Identification of blood-derived candidate gene markers and a new 7-gene diagnostic model for multiple sclerosis. Biol Res. 2021;54(1):12.","journal-title":"Biol Res"},{"key":"4231_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"4231_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"4","key":"4231_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","volume":"16","author":"R Tibshirani","year":"1997","unstructured":"Tibshirani R. The Lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385\u201395.","journal-title":"Stat Med"},{"key":"4231_CR19","doi-asserted-by":"publisher","first-page":"102011","DOI":"10.1016\/j.nicl.2019.102011","volume":"24","author":"V Wottschel","year":"2019","unstructured":"Wottschel V, Chard DT, Enzinger C, Filippi M, Frederiksen JL, Gasperini C, et al. SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage Clin. 2019;24:102011.","journal-title":"Neuroimage Clin"},{"key":"4231_CR20","doi-asserted-by":"publisher","first-page":"175628642110019","DOI":"10.1177\/17562864211001977","volume":"14","author":"S Engel","year":"2021","unstructured":"Engel S, Protopapa M, Steffen F, Papanastasiou V, Nicolaou C, Protopapas M, et al. Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis. Ther Adv Neurol Disord. 2021;14:17562864211001977.","journal-title":"Ther Adv Neurol Disord"},{"issue":"7","key":"4231_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-021-00498-5","volume":"17","author":"MT Cencioni","year":"2021","unstructured":"Cencioni MT, Mattoscio M, Magliozzi R, Bar-Or A, Muraro PA. B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies. Nat Rev Neurol. 2021;17(7):399\u2013414.","journal-title":"Nat Rev Neurol"},{"key":"4231_CR22","doi-asserted-by":"crossref","unstructured":"Marsh-Wakefield F, Juillard P, Ashhurst TM, Juillard A, Shinko D, Putri GH et al. Peripheral B cell dysregulation is associated with relapse after long-term quiescence in multiple sclerosis patients. Immunol Cell Biol. (2022).","DOI":"10.1111\/imcb.12552"},{"issue":"3","key":"4231_CR23","doi-asserted-by":"publisher","first-page":"e59842","DOI":"10.1371\/journal.pone.0059842","volume":"8","author":"M Bernal-Quir\u00f3s","year":"2013","unstructured":"Bernal-Quir\u00f3s M, Wu YY, Alarc\u00f3n-Riquelme ME, Castillejo-L\u00f3pez C. BANK1 and BLK act through phospholipase C gamma 2 in B-cell signaling. PLoS ONE. 2013;8(3):e59842.","journal-title":"PLoS ONE"},{"issue":"8","key":"4231_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00011-019-01253-9","volume":"68","author":"J Ram\u00edrez-Bello","year":"2019","unstructured":"Ram\u00edrez-Bello J, Jim\u00e9nez-Morales S, Montufar-Robles I, Fragoso JM, Barbosa-Cobos RE, Saavedra MA, et al. BLK and BANK1 polymorphisms and interactions are associated in Mexican patients with systemic lupus erythematosus. Inflamm Res. 2019;68(8):705\u201313.","journal-title":"Inflamm Res"},{"issue":"11","key":"4231_CR25","doi-asserted-by":"publisher","first-page":"9965","DOI":"10.1007\/s11033-012-1865-8","volume":"39","author":"H Zhang","year":"2012","unstructured":"Zhang H, Wang L, Huang Y, Zhuang C, Zhao G, Liu R, et al. Influence of BLK polymorphisms on the risk of rheumatoid arthritis. Mol Biol Rep. 2012;39(11):9965\u201370.","journal-title":"Mol Biol Rep"},{"issue":"12","key":"4231_CR26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/cns.13738","volume":"27","author":"BW Yin","year":"2021","unstructured":"Yin BW, Li B, Mehmood A, Yuan C, Song S, Guo RY, et al. BLK polymorphisms and expression level in neuromyelitis Optica spectrum disorder. CNS Neurosci Ther. 2021;27(12):1549\u201360.","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"4231_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","volume":"82","author":"RA North","year":"2002","unstructured":"North RA. Molecular physiology of P2X receptors. Physiol Rev. 2002;82(4):1013\u201367.","journal-title":"Physiol Rev"},{"issue":"9","key":"4231_CR28","doi-asserted-by":"publisher","first-page":"e104692","DOI":"10.1371\/journal.pone.0104692","volume":"9","author":"P Abramowski","year":"2014","unstructured":"Abramowski P, Ogrodowczyk C, Martin R, Pongs O. A Truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLoS ONE. 2014;9(9):e104692.","journal-title":"PLoS ONE"},{"key":"4231_CR29","doi-asserted-by":"publisher","first-page":"591894","DOI":"10.3389\/fneur.2020.591894","volume":"11","author":"R Chunder","year":"2020","unstructured":"Chunder R, Schropp V, Kuerten S. B cells in multiple sclerosis and Virus-Induced neuroinflammation. Front Neurol. 2020;11:591894. https:\/\/doi.org\/10.3389\/fneur.2020.591894. Published 2020 Nov 3.","journal-title":"Front Neurol"},{"issue":"6","key":"4231_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1089\/wound.2017.0773","volume":"7","author":"VB Morhenn","year":"2018","unstructured":"Morhenn VB. The relationship of wound healing with psoriasis and multiple sclerosis. Adv Wound Care (New Rochelle). 2018;7(6):185\u20138. https:\/\/doi.org\/10.1089\/wound.2017.0773.","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"6","key":"4231_CR31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(24)00140-6","volume":"23","author":"A Haghikia","year":"2024","unstructured":"Haghikia A, Schett G, Mougiakakos D. B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases. Lancet Neurol. 2024;23(6):615\u201324. https:\/\/doi.org\/10.1016\/S1474-4422(24)00140-6.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4231_CR32","doi-asserted-by":"publisher","first-page":"102276","DOI":"10.1016\/j.rpth.2023.102276","volume":"8","author":"TCL Kohs","year":"2023","unstructured":"Kohs TCL, Vu HH, Jordan KR, et al. Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia. Res Pract Thromb Haemost. 2023;8(1):102276. https:\/\/doi.org\/10.1016\/j.rpth.2023.102276. Published 2023 Nov 27.","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"4231_CR33","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3390\/cells10061548","volume":"10","author":"MN Mithaiwala","year":"2021","unstructured":"Mithaiwala MN, Santana-Coelho D, Porter GA, O\u2019Connor JC. Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications. Cells. 2021;10(6):1548. https:\/\/doi.org\/10.3390\/cells10061548. Published 2021 Jun 19.","journal-title":"Cells"},{"issue":"3","key":"4231_CR34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s12026-007-8009-6","volume":"40","author":"S Oh","year":"2008","unstructured":"Oh S, Cudrici C, Ito T, Rus H. B-cells and humoral immunity in multiple sclerosis. Implications for therapy. Immunol Res. 2008;40(3):224\u201334. https:\/\/doi.org\/10.1007\/s12026-007-8009-6.","journal-title":"Immunol Res"},{"issue":"1","key":"4231_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cvr\/cvr040","volume":"91","author":"CJ Kuckleburg","year":"2011","unstructured":"Kuckleburg CJ, Yates CM, Kalia N, et al. Endothelial cell-borne platelet bridges selectively recruit monocytes in human and mouse models of vascular inflammation. Cardiovasc Res. 2011;91(1):134\u201341. https:\/\/doi.org\/10.1093\/cvr\/cvr040.","journal-title":"Cardiovasc Res"},{"key":"4231_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cyto.2018.02.022","volume":"109","author":"P Ruytinx","year":"2018","unstructured":"Ruytinx P, Proost P, Struyf S. CXCL4 and CXCL4L1 in cancer. Cytokine. 2018;109:65\u201371.","journal-title":"Cytokine"},{"issue":"2","key":"4231_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1600-0404.1987.tb03550.x","volume":"76","author":"AR Cananzi","year":"1987","unstructured":"Cananzi AR, Ferro-Milone F, Grigoletto F, Toldo M, Meneghini F, Bortolon F, et al. Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis. Acta Neurol Scand. 1987;76(2):79\u201385.","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"4231_CR38","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/09537104.2017.1361526","volume":"28","author":"M Othman","year":"2017","unstructured":"Othman M, Emsley J. Gene of the issue: GP1BA gene mutations associated with bleeding. Platelets. 2017;28(8):832\u20136.","journal-title":"Platelets"},{"issue":"12","key":"4231_CR39","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/jth.14597","volume":"17","author":"A Tischer","year":"2019","unstructured":"Tischer A, Machha VR, Moon-Tasson L, Auton M. Platelet-type von Willebrand disease: local disorder of the platelet GPIb\u03b1 \u03b2-switch drives high-affinity binding to von Willebrand factor. J Thromb Haemost. 2019;17(12):2022\u201334.","journal-title":"J Thromb Haemost"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04231-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:40:24Z","timestamp":1751359224000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04231-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4231"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04231-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Ethics Committee of Zhuzhou Central Hospital (approval number: ZZCHEC2000044-01). This study was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}